{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:08:04Z","timestamp":1777486084855,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["989320"],"award-info":[{"award-number":["989320"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["950877"],"award-info":[{"award-number":["950877"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ab.2026.116071","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:45:43Z","timestamp":1770047143000},"page":"116071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and in vitro evaluation of an Fc-fusion epitope-based vaccine candidate against Helicobacter pylori"],"prefix":"10.1016","volume":"712","author":[{"given":"Roghayeh","family":"Mohammadzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaho","family":"Menbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janbibi","family":"Dorazehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Sankian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3420-5058","authenticated-orcid":false,"given":"Hadi","family":"Farsiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2026.116071_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ab.2026.116071_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.713955","article-title":"Helicobacter pylori in human stomach: the inconsistencies in clinical outcomes and the probable causes","volume":"12","author":"Alexander","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ab.2026.116071_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12636","article-title":"Helicobacter pylori and extragastric diseases","volume":"24","author":"Franceschi","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.ab.2026.116071_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.ab.2026.116071_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13103","article-title":"Global primary antibiotic resistance rate of Helicobacter pylori in recent 10 years: a systematic review and meta\u2010analysis","volume":"29","author":"Yu","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.ab.2026.116071_bib6","first-page":"1","article-title":"Developing a potent vaccine against Helicobacter pylori: critical considerations and challenges","author":"Haghighi","year":"2024","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.ab.2026.116071_bib7","first-page":"1","article-title":"Helicobacter pylori virulence factors: subversion of host immune system and development of various clinical outcomes","author":"Mohammadzadeh","year":"2023","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.ab.2026.116071_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12428","article-title":"Immunologic properties and therapeutic efficacy of a multivalent epitope\u2010based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils","volume":"22","author":"Guo","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.ab.2026.116071_bib9","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1016\/j.vaccine.2005.07.021","article-title":"Human immune response towards recombinant Helicobacter pylori urease and cellular fractions","volume":"24","author":"Voland","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ab.2026.116071_bib10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1586\/erv.09.62","article-title":"Development of vaccines against Helicobacter pylori","volume":"8","author":"Del Giudice","year":"2009","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.ab.2026.116071_bib11","article-title":"Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB\/c mice","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ab.2026.116071_bib12","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/S0264-410X(02)00223-2","article-title":"Serum-derived IgG1-mediated immune exclusion as a mechanism of protection against H. pylori infection","volume":"20","author":"Keenan","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ab.2026.116071_bib13","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1128\/IAI.68.6.3337-3343.2000","article-title":"Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate","volume":"68","author":"Keenan","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ab.2026.116071_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/hel.12268","article-title":"Antibody production and Th1\u2010biased response induced by an epitope vaccine composed of cholera toxin B unit and Helicobacter pylori Lpp20 epitopes","volume":"21","author":"Li","year":"2016","journal-title":"Helicobacter"},{"key":"10.1016\/j.ab.2026.116071_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-13-68","article-title":"Identification and characterization of H-2 d restricted CD4+ T cell epitopes on Lpp20 of Helicobacter pylori","volume":"13","author":"Li","year":"2012","journal-title":"BMC Immunol."},{"key":"10.1016\/j.ab.2026.116071_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/1040841X.2021.1979934","article-title":"Designing and development of epitope-based vaccines against Helicobacter pylori","volume":"48","author":"Mohammadzadeh","year":"2022","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.ab.2026.116071_bib17","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.tibtech.2024.05.004","article-title":"Recombinant immune complexes as vaccines against infectious diseases","volume":"42","author":"Kim","year":"2024","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.ab.2026.116071_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s002620050418","article-title":"Increased potency of Fc-receptor-targeted antigens","volume":"45","author":"Guyre","year":"1997","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ab.2026.116071_bib19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00705-009-0423-8","article-title":"Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors","volume":"154","author":"Martyn","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ab.2026.116071_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tibtech.2014.11.001","article-title":"Fc fusion as a platform technology: potential for modulating immunogenicity","volume":"33","author":"Levin","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ab.2026.116071_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/82_2019_154","article-title":"Fc receptors in antimicrobial protection","author":"Wieland","year":"2019","journal-title":"Fc Mediated Activity of Antibodies: Structural and Functional Diversity"},{"key":"10.1016\/j.ab.2026.116071_bib22","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1039\/C6MB00174B","article-title":"Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6: CFP-10 complex","volume":"12","author":"Farsiani","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ab.2026.116071_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.meegid.2016.01.027","article-title":"Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine","volume":"39","author":"Mosavat","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ab.2026.116071_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120920","article-title":"Selective APC-targeting of a novel Fc-fusion multi-immunodominant recombinant protein (tTax-tEnv: mFc\u03b32a) for HTLV-1 vaccine development","volume":"308","author":"Shafifar","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ab.2026.116071_bib25","doi-asserted-by":"crossref","first-page":"10467","DOI":"10.1007\/s00253-015-6952-z","article-title":"APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice","volume":"99","author":"Soleimanpour","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ab.2026.116071_bib26","article-title":"The influence of adjuvant on UreB protection against Helicobacter pylori through the diversity of CD4+ T-cell epitope repertoire","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ab.2026.116071_bib27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3389\/fmicb.2018.00884","article-title":"Identification of two Lpp20 CD4+ T cell epitopes in Helicobacter pylori-infected subjects","volume":"9","author":"Ning","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ab.2026.116071_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.155","article-title":"Practical methods for expression of recombinant protein in the Pichia pastoris System","volume":"1","author":"Mohammadzadeh","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.ab.2026.116071_bib29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/14760584.2021.1945450","article-title":"Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape","volume":"20","author":"Dos Santos Viana","year":"2021","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.ab.2026.116071_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12926","article-title":"Perspectives from recent advances of Helicobacter pylori vaccines research","volume":"27","author":"Zhang","year":"2022","journal-title":"Helicobacter"},{"key":"10.1016\/j.ab.2026.116071_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12405","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"22","author":"Camilo","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.ab.2026.116071_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12406","article-title":"Helicobacter: inflammation, immunology and vaccines","volume":"22","author":"Robinson","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.ab.2026.116071_bib33","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/emmm.201201379","article-title":"Fc\u2010fusion proteins: new developments and future perspectives","volume":"4","author":"Czajkowsky","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ab.2026.116071_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114347","article-title":"Development of a recombinant vaccine containing a spike S1-Fc fusion protein induced protection against MERS-CoV in human DPP4 knockin transgenic mice","volume":"299","author":"Jung","year":"2022","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ab.2026.116071_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07388551.2013.834293","article-title":"Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics","volume":"35","author":"Rath","year":"2015","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.ab.2026.116071_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-4-33","article-title":"Immunogenicity of the outer domain of a HIV-1 clade C gp120","volume":"4","author":"Chen","year":"2007","journal-title":"Retrovirology"},{"key":"10.1016\/j.ab.2026.116071_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.vaccine.2008.11.083","article-title":"Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ab.2026.116071_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00267-22","article-title":"Disruption of sncRNA improves the protective efficacy of outer membrane vesicles against Helicobacter pylori infection in a mouse model","volume":"90","author":"Li","year":"2022","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ab.2026.116071_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00313-23","article-title":"Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against Helicobacter pylori infection in mice","volume":"91","author":"Liu","year":"2023","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ab.2026.116071_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70085","article-title":"Development of a recombinant outer membrane vesicles (OMVs)\u2010Based vaccine Against Helicobacter pylori infection in mice","volume":"14","author":"Liu","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ab.2026.116071_bib41","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2367783","article-title":"Outer membrane vesicles from genetically engineered Salmonella enterica serovar Typhimurium presenting Helicobacter pylori antigens UreB and CagA induce protection against Helicobacter pylori infection in mice","volume":"15","author":"Liu","year":"2024","journal-title":"Virulence"},{"key":"10.1016\/j.ab.2026.116071_bib42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/07388551.2016.1163323","article-title":"Fc\u03b31 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: immunological, biochemical and therapeutic properties","volume":"37","author":"Soleimanpour","year":"2017","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.ab.2026.116071_bib43","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca - Cancer J. Clin."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269726000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269726000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:27:22Z","timestamp":1777386442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269726000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"alternative-id":["S0003269726000278"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2026.116071","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and in vitro evaluation of an Fc-fusion epitope-based vaccine candidate against Helicobacter pylori","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2026.116071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116071"}}